Table 2.
Group BA 24 | Sample size | [3 H]DAMGO binding (fmole/mg ETE) | Analysis parameters | P value |
---|---|---|---|---|
Suicide |
41 |
32.25 ± 1.76 |
t = 2.7, df = 120 (non-suicide) |
0.008 |
Non-suicide |
81 |
38.34 ± 1.34 |
|
|
Diagnosis/suicide |
BA 24 |
|
|
|
Controls |
51 |
37.63 ± 1.83 |
|
|
Suicides |
9 |
34.02 ± 3.80 |
t = 0.88 (controls) |
n.s |
MDD |
5 |
27.95 ± 9.06 |
t = 1.84 (controls) |
n.s |
MDD (suicide) |
15 |
35.69 ± 2.84 |
t = 0.58 (controls) |
n.s |
BP |
8 |
50.51 ± 1.98 |
t = 3.00 (controls) |
n.s |
BP (suicide) |
5 |
35.38 ± 3.07 |
t = 0.43 (controls) |
n.s |
Schizophrenia |
26 |
37.80 ± 1.83 |
t = 0.04 (controls) |
n.s |
Schizophrenia (suicide) |
12 |
25.31 ± 3.17 |
t = 3.39 (controls) t = 3.21 (schizophrenia) |
<0.05 |
Schizophrenia/suicide |
BA 9 |
|
|
|
Controls |
20 |
31.65 ± 2.11 |
|
|
Schizophrenia |
26 |
34.40 ± 1.32 |
t = 1.15 (controls) |
n.s |
Schizophrenia (suicide) |
12 |
24.12 ± 2.27 |
t = 2.57 (controls) t = 3.68 (schizophrenia) |
<0.05 <0.05 |
|
CPu |
|
|
|
Controls |
20 |
25.40 ± 2.16 |
|
|
Schizophrenia |
24 |
23.72 ± 1.37 |
t = 0.67 (controls) |
n.s |
Schizophrenia (suicide) | 11 | 16.29 ± 2.42 | t = 2.97 (controls) t = 2.50 (schizophrenia) | <0.05 <0.05 |
The group comparison the analysis factors refer to is given in brackets below the parameters. Abbreviations: n.s. = not significant.